Furthermore, treating mice undergoing experimental colitis with an NAD+ precursor, nicotinamide riboside (NR), decreased the severity of colitis, restored mitochondrial function, and decreased the levels of acetylated (inactive) PGC1α. The gene discussed is PPARGC1A; the disease is colitis.